Spirometer Market size is valued at USD 1.12 Bn in 2023 and is expected to reach USD 2.39 Bn by 2031, and grow at a CAGR of 10.17% over the forecast period of 2024-2031.
A spirometer is a medical tool used to assess respiratory health and measure lung function. It is frequently used to evaluate lung function, airflow, and the overall effectiveness of the respiratory system in clinics, hospitals, and research settings. A diagnostic procedure called spirometry gives accurate measures of lung contents and airflow. Spirometry is primarily used to detect and track lung disorders such chronic obstructive pulmonary disease (COPD), asthma, and other lung conditions. Additionally, it is used to gauge how well therapy regimens are working and chart the evolution of respiratory disorders over time. A person does a spirometry test by breathing into a spirometer, which records several respiratory function characteristics. Spirometry's most significant measurements are Forced Vital Capacity (FVC): The most air that can be forcibly exhaled by a person obeying a deep breath. The amount of air forcedly expelled in the first second of the forced vital capacity test is known as the forced expiratory volume in one second (FEV1). The proportion of the FVC exhaled in the first second is known as the FEV1/FVC ratio. These metrics assist medical experts in evaluating lung function and identifying any airflow obstructions or limitations. The patient's peak expiratory flow rate (PEFR), which measures the greatest airflow attained during forced exhalation, is one example of the additional information that spirometry can offer.
Get More Information on Spirometer Market - Request Sample Report
Driver
The spirometer driver software or device normally offers an interface for directing the user through the spirometry testing procedure, collecting, and processing the data from the patient's breathing manoeuvres, and producing pertinent measurements and graphical representations.
Restrain
Spirometry is a non-invasive treatment in which the patient voluntarily engages in a series of breathing manoeuvres designed to assess various aspects of lung function. Take a deep breath in and aggressively exhale into the spirometer as part of these techniques. In order to get reliable findings, the patient is typically urged to put out their best effort and cooperation during the manoeuvres.
Opportunity
Monitoring and Diagnosis: Spirometry gives medical practitioners the chance to precisely identify and keep track of respiratory disorders. Spirometry assists in detecting anomalies in airflow and determining the severity of respiratory disorders like asthma, COPD, and pulmonary fibrosis by measuring lung function parameters like forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). The course of the disease and lung function can be continuously monitored with routine spirometry testing.
Challenge
Spirometry results may be impacted by specific patient characteristics. Age, body position, effort, and test comprehension are a few variables that can affect measurements. Some people, especially those with severe respiratory diseases or physical restrictions, may find it difficult to fully perform the necessary breathing manoeuvres. To get accurate and insightful results from spirometry testing, these factors must be considered and properly addressed.
Supply chains could be hampered by the conflict, making it difficult to distribute and import medical equipment like spirometers. The acquisition and delivery of spirometry equipment and associated supplies may be hampered by trade disruptions, transportation issues, and infrastructure damage. The war may result in economic instability, which may influence the money and resources available to the healthcare system. Investments in healthcare infrastructure, such as spirometry equipment and training for healthcare personnel, may be curtailed as a result of financial restrictions.
Impact of Recession :
During a recession, healthcare expenditures frequently are cut as governments and organisations try to save money. This may result in spirometer purchases and maintenance having a limited budget. As a result, healthcare organisations might need to set spending priorities and devote fewer funds to getting new spirometry equipment or upgrading their current inventory. Delayed Upgrades and Replacement: Healthcare providers may postpone the acquisition of new spirometers or put off replacing existing versions during difficult economic times. This could result in an outdated inventory of spirometry equipment, which might affect the precision and dependability of measurements. Older technology could be deficient in modern capabilities and enhancements available in newer devices.
By Product
Devices
Software
Consumables & Accessories
By Technology
Volume Measurement
Flow Measurement
Peak Flow Measurement
By Application
Asthma
COPD
Cystic Fibrosis
Pulmonary Fibrosis
Others
By End use
Hospitals and Clinics
Home Healthcare
North America is the region with the highest share because of the rising technological advancement and the rising investment in the developed countries regarding the same. Spirometry is frequently employed in therapeutic settings in North America. Spirometry is a tool used by healthcare professionals to diagnose and track respiratory disorders like asthma, COPD, and pulmonary fibrosis. These professionals include primary care doctors, pulmonologists, and respiratory therapists. Spirometry is regarded as a common diagnostic tool for assessing lung function and directing therapeutic choices.
European nations abide by the rules and criteria established by groups like the European Lung Foundation (ELF) and the European Respiratory Society (ERS). These recommendations cover spirometry testing procedures, quality control, equipment calibration, and spirometry result interpretation. Spirometry measurements are standardised and trustworthy when certain rules are followed.
Schiller, Smiths Medical, Vyaire Medical, SDI Diagnostics, nSpire Health, Fukuda Sangyo, Sibelmed, Vitalograph, Geratherm Respiratory, Koninklijke Philips, Welch Allyn.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.12 Bn |
| Market Size by 2031 | US$ 2.39 Bn |
| CAGR | CAGR of 10.17 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Devices, Software, Consumables & Accessories) • By Technology (Volume Measurement, Flow Measurement, Peak Flow Measurement) • By Application (Asthma, COPD, Cystic Fibrosis, Pulmonary Fibrosis, Others) • By End Use (Hospitals and Clinics, Home Healthcare) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Schiller, Smiths Medical, Vyaire Medical, SDI Diagnostics, nSpire Health, Fukuda Sangyo, Sibelmed, Vitalograph, Geratherm Respiratory, Koninklijke Philips, Welch Allyn. |
| Key Drivers | • The spirometer driver software or device normally offers an interface for directing the user through the spirometry testing procedure, collecting, and processing the data from the patient's breathing manoeuvres, and producing pertinent measurements and graphical representations. |
| Market Opportunities | • Monitoring and Diagnosis |
Ans: The spirometer driver software or device normally offers an interface for directing the user through the spirometry testing procedure, collecting, and processing the data from the patient's breathing manoeuvres, and producing pertinent measurements and graphical representations.
Ans: Spirometry is a non-invasive treatment in which the patient voluntarily engages in a series of breathing manoeuvres designed to assess various aspects of lung function.
Ans: The Spirometer Market size is valued at USD 1 Bn in 2022 and is expected to reach USD 2.16 Bn by 2030, and grow at a CAGR of 10.15% over the forecast period of 2023-2030.
Ans: Schiller, Smiths Medical, Vyaire Medical, SDI Diagnostics, nSpire Health, Fukuda Sangyo, Sibelmed, Vitalograph, Geratherm Respiratory, Koninklijke Philips, Welch Allyn.
Ans: The market is divided in four segments.
Table of Contents
1.Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2.Research Methodology
3.Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4.Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5.Value Chain Analysis
6.Porter’s 5 forces model
7.PEST Analysis
8.Spirometer Market Segmentation, by Product
8.1 Skin Infections
8.2 Respiratory Infections
8.3 Urinary Tract Infections
8.4 Ear Infections
8.5 Others
9.Spirometer Market Segmentation, by Technology
9.1 Penicillin
9.2 Macrolides
9.3 Tetracycline
9.4 Others
10.Spirometer Market Segmentation, by Application
10.1 Oral
10.2 Parental
10.3 Others
11.Spirometer Market Segmentation, by End Use
11.1 Retail Pharmacy
11.2 Hospital based Pharmacy
11.3 Online Pharmacy
11.4 Others
12.Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Spirometer Market by country
12.2.2North America Spirometer Market by Product
12.2.3 North America Spirometer Market by Technology
12.2.4 North America Spirometer Market by Application
12.2.5 North America Spirometer Market by End Use
12.2.6 USA
12.2.6.1 USA Spirometer Market by Product
12.2.6.2 USA Spirometer Market by Technology
12.2.6.3 USA Spirometer Market by Application
12.2.6.4 USA Spirometer Market by End Use
12.2.7 Canada
12.2.7.1 Canada Spirometer Market by Product
12.2.7.2 Canada Spirometer Market by Technology
12.2.7.3 Canada Spirometer Market by Application
12.2.7.4 Canada Spirometer Market by End Use
12.2.8 Mexico
12.2.8.1 Mexico Spirometer Market by Product
12.2.8.2 Mexico Spirometer Market by Technology
12.2.8.3 Mexico Spirometer Market by Application
12.2.8.4 Mexico Spirometer Market by End Use
12.3 Europe
12.3.1 Europe Spirometer Market by country
1.3.3.2 Europe Spirometer Market by Product
12.3.3 Europe Spirometer Market by Technology
12.3.4 Europe Spirometer Market by Application
12.3.5 Europe Spirometer Market by End Use
12.3.6 Germany
12.3.6.1 Germany Spirometer Market by Product
12.3.6.2 Germany Spirometer Market by Technology
12.3.6.3 Germany Spirometer Market by Application
12.3.6.4 Germany Spirometer Market by End Use
12.3.7 UK
12.3.7.1 UK Spirometer Market by Product
12.3.7.2 UK Spirometer Market by Technology
12.3.7.3 UK Spirometer Market by Application
12.3.7.4 UK Spirometer Market by End Use
12.3.8 France
12.3.8.1 France Spirometer Market by Product
12.3.8.2 France Spirometer Market by Technology
12.3.8.3 France Spirometer Market by Application
12.3.8.4 France Spirometer Market by End Use
12.3.9 Italy
12.3.9.1 Italy Spirometer Market by Product
12.3.9.2 Italy Spirometer Market by Technology
12.3.9.3 Italy Spirometer Market by Application
12.3.9.4 Italy Spirometer Market by End Use
12.3.10 Spain
12.3.10.1 Spain Spirometer Market by Product
12.3.10.2 Spain Spirometer Market by Technology
12.3.10.3 Spain Spirometer Market by Application
12.3.10.4 Spain Spirometer Market by End Use
12.3.11 The Netherlands
12.3.11.1 Netherlands Spirometer Market by Product
12.3.11.2 Netherlands Spirometer Market by Technology
12.3.11.3 Netherlands Spirometer Market by Application
12.3.11.4 Netherlands Spirometer Market by End Use
12.3.12 Rest of Europe
12.3.12.1 Rest of Europe Spirometer Market by Product
12.3.12.2 Rest of Europe Spirometer Market by Technology
12.3.12.3 Rest of Europe Spirometer Market by Application
12.3.12.4 Rest of Europe Spirometer Market by End Use
12.4 Asia-Pacific
12.4.1 Asia Pacific Spirometer Market by country
12.4.2 Asia Pacific Spirometer Market by Product
12.4.3 Asia Pacific Spirometer Market by Technology
12.4.4Asia Pacific Spirometer Market by Application
12.4.5Asia Pacific Spirometer Market by End Use
12.4.6 Japan
12.4.6.1 Japan Spirometer Market by Product
12.4.6.2 Japan Spirometer Market by Technology
12.4.6.3 Japan Spirometer Market by Application
12.4.6.4 Japan Spirometer Market by End Use
12.4.7 South Korea
12.4.7.1 South Korea Spirometer Market by Product
12.4.7.2 South Korea Spirometer Market by Technology
12.4.7.3 South Korea Spirometer Market by Application
12.4.7.4 South Korea Spirometer Market by End Use
12.4.8 China
12.4.8.1 China Spirometer Market by Product
12.4.8.2 China Spirometer Market by Technology
12.4.8.3 China Spirometer Market by Application
12.4.8.4 China Spirometer Market by End Use
12.4.9 India
12.4.9.1 India Spirometer Market by Product
12.4.9.2 India Spirometer Market by Technology
12.4.9.3 India Spirometer Market by Application
12.4.9.4 India Spirometer Market by End Use
12.4.10 Australia
12.4.10.1 Australia Spirometer Market by Product
12.4.10.2 Australia Spirometer Market by Technology
12.4.10.3 Australia Spirometer Market by Application
12.4.10.4 Australia Spirometer Market by End Use
12.4.11 Rest of Asia-Pacific
12.4.11.1 APAC Spirometer Market by Product
12.4.11.2 APAC Spirometer Market by Technology
12.4.11.3 APAC Spirometer Market by Application
12.4.11.4 APAC Spirometer Market by End Use
12.5 The Middle East & Africa
12.5.1 The Middle East & Africa Spirometer Market by country
12.5.2 The Middle East & Africa Spirometer Market by Product
12.5.3 The Middle East & Africa Spirometer Market by Technology
12.5.4The Middle East & Africa Spirometer Market by Application
12.5.5 The Middle East & Africa Spirometer Market by End Use
12.5.6 Israel
12.5.6.1 Israel Spirometer Market by Product
12.5.6.2 Israel Spirometer Market by Technology
12.5.6.3 Israel Spirometer Market by Application
12.5.6.4 Israel Spirometer Market by End Use
12.5.7 UAE
12.5.7.1 UAE Spirometer Market by Product
12.5.7.2 UAE Spirometer Market by Technology
12.5.7.3 UAE Spirometer Market by Application
12.5.7.4 UAE Spirometer Market by End Use
12.5.8 South Africa
12.5.8.1 South Africa Spirometer Market by Product
12.5.8.2 South Africa Spirometer Market by Technology
12.5.8.3 South Africa Spirometer Market by Application
12.5.8.4 South Africa Spirometer Market by End Use
12.5.9 Rest of Middle East & Africa
12.5.9.1 Rest of Middle East & Asia Spirometer Market by Product
12.5.9.2 Rest of Middle East & Asia Spirometer Market by Technology
12.5.9.3 Rest of Middle East & Asia Spirometer Market Application
12.5.9.4 Rest of Middle East & Asia Spirometer Market by End Use
12.6 Latin America
12.6.1 Latin America Spirometer Market by country
12.6.2 Latin America Spirometer Market by Product
12.6.3 Latin America Spirometer Market by Technology
12.6.4 Latin America Spirometer Market by Application
12.6.5 Latin America Spirometer Market by End Use
12.6.6 Brazil
12.6.6.1 Brazil Spirometer Market by Product
12.6.6.2 Brazil Africa Spirometer Market by Technology
12.6.6.3 Brazil Spirometer Market by Application
12.6.6.4 Brazil Spirometer Market by End Use
12.6.7 Argentina
12.6.7.1 Argentina Spirometer Market by Product
12.6.7.2 Argentina Spirometer Market by Technology
12.6.7.3 Argentina Spirometer Market by Application
12.6.7.4 Argentina Spirometer Market by End Use
12.6.8 Rest of Latin America
12.6.8.1 Rest of Latin America Spirometer Market by Product
12.6.8.2 Rest of Latin America Spirometer Market by Technology
12.6.8.3 Rest of Latin America Spirometer Market by Application
12.6.8.4 Rest of Latin America Spirometer Market by End Use
13.Company profile
13.1 Pfizer
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Products/Services/Offerings
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Abbott
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Products/Services/Offerings
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Sanofi
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Products/Services/Offerings
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Bayer AG
13.4.1 Market Overview
13.4.2 Financials
13.4.3 Products/Services/Offerings
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Merck & Co
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Products/Services/Offerings
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Johnson & Johnson
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Products/Services/Offerings
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Astellas Pharma
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Products/Services/Offerings
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 GlaxoSmithKline
13.8.1 Market Overview
13.8.2 Financials
13.8.3 Products/Services/Offerings
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Novartis AG
13.9.1 Market Overview
13.9.2 Financials
13.9.3 Products/Services/Offerings
13.9.4 SWOT Analysis
13.9.5 The SNS View
14.Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share analysis
14.3 Recent Developments
15. Used Cases & Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The 3D Printed Brain Model Market Size was valued at USD 32.82 million in 2022 and is expected to reach USD 109.11 million by 2030, and grow at a CAGR of 16.2% over the forecast period 2023-2030.
The Cardiology Information System (CIS) Market Size was valued at USD 1051.77 million in 2022, and is expected to reach USD 2158.03 million by 2030, and grow at a CAGR of 9.4% over the forecast period 2023-2030.
The Albumin Market size was estimated USD 0.9 billion in 2022 and is expected to reach USD 1.43 billion by 2030 at a CAGR of 6.0% during the forecast period of 2023-2030.
The Blood Testing Market Size was valued at USD 98.3 billion in 2023 and is expected to reach USD 172.7 billion by 2031 and grow at a CAGR of 7.3% over the forecast period 2024-2031.
The Mononucleosis Diagnostic Market size was estimated USD 1.7 billion in 2022 and is expected to reach USD 3.2 billion by 2030 at a CAGR of 8.6% during the forecast period of 2023-2030.
The Cancer biomarkers market size was estimated USD 13.21 billion in 2022 and is expected to reach USD 36.89 billion By 2030 at a CAGR of 13.7% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
